Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Tesaro Inc (TSRO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,826,584
  • Shares Outstanding, K 54,800
  • Annual Sales, $ 223,330 K
  • Annual Income, $ -496,130 K
  • 36-Month Beta 1.34
  • Price/Sales 12.81
  • Price/Cash Flow N/A
  • Price/Book 11.40

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.67 +1.80%
on 04/09/18
64.26 -19.73%
on 03/22/18
-8.17 (-13.67%)
since 03/20/18
3-Month
50.67 +1.80%
on 04/09/18
74.78 -31.02%
on 01/23/18
-12.33 (-19.29%)
since 01/19/18
52-Week
50.67 +1.80%
on 04/09/18
168.92 -69.46%
on 05/31/17
-87.43 (-62.89%)
since 04/20/17

Most Recent Stories

More News
New Research Coverage Highlights MPLX LP, TESARO, LKQ, Cytokinetics, Keysight Technologies, and Charles River Laboratories International -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MPLX LP (NYSE:MPLX), TESARO,...

CYTK : 7.15 (+0.70%)
LKQ : 38.25 (-0.98%)
KEYS : 53.56 (-1.02%)
MPLX : 33.86 (-0.09%)
TSRO : 51.58 (-1.21%)
CRL : 105.46 (-0.51%)
TESARO to Announce First-Quarter 2018 Financial Results on May 3, 2018

TESARO, Inc. (NASDAQ:TSRO) will announce first-quarter 2018 financial results on Thursday, May 3, 2018, after the close of the U.S. financial markets. TESARO's senior management team will host a conference...

TSRO : 51.58 (-1.21%)
Tesaro Inc Shares Down 9.5% Since SmarTrend's Sell Call (TSRO)

SmarTrend identified a Downtrend for Tesaro Inc (NASDAQ:TSRO) on March 19th, 2018 at $61.31. In approximately 4 weeks, Tesaro Inc has returned 9.46% as of today's recent price of $55.51.

TSRO : 51.58 (-1.21%)
Noteworthy Monday Option Activity: TSRO, ERI, WSM

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Tesaro Inc , where a total volume of 11,215 contracts has been traded thus far today,...

TSRO : 51.58 (-1.21%)
TESARO Summarizes TSR-042 Clinical Data Presented at AACR

-- Activity of TSR-042 (anti-PD-1 antibody) monotherapy demonstrated in patients with MSI-high endometrial and non-small cell lung cancers

TSRO : 51.58 (-1.21%)
TESARO and Medison Enter Into Exclusive Distribution Agreement to Commercialize ZEJULA(R) in Israel

- Agreement covers all indications for ZEJULA, excluding prostate cancer

TSRO : 51.58 (-1.21%)
Look for Shares of Tesaro Inc to Potentially Rebound after Yesterday's 5.54% Sell Off

Tesaro Inc (NASDAQ:TSRO) traded in a range yesterday that spanned from a low of $51.22 to a high of $55.70. Yesterday, the shares fell 5.5%, which took the trading range below the 3-day low of $53.50...

TSRO : 51.58 (-1.21%)
Clovis' (CLVS) Rubraca Gets FDA Nod as Maintainence Therapy

Clovis Oncology (CLVS) announces the FDA has granted label expansion of Rubraca to include maintenance treatment of ovarian cancer patients in second line setting, irrespective of BRCA mutation status....

AZN : 35.34 (-0.17%)
CLVS : 50.17 (-2.24%)
TSRO : 51.58 (-1.21%)
PFE : 36.63 (+0.27%)
Technical Perspectives on Biotech Stocks -- Tesaro, Trevena, Vanda Pharma, and Verastem

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on TSRO, TRVN, VNDA, and VSTM which can be accessed for free by signing up to www.wallstequities.com/registration....

TRVN : 1.73 (-1.14%)
TSRO : 51.58 (-1.21%)
VNDA : 14.85 (+0.68%)
VSTM : 4.20 (+1.20%)
Data From TOPACIO Trial Reported at SGO Demonstrates Compelling Clinical Activity of ZEJULA in Combination With an Anti-PD-1 Antibody in Patients With Platinum Resistant/Refractory Ovarian Cancer

-- Efficacy of niraparib in combination with an anti-PD-1 mAb surpasses historical efficacy benchmarks for PD-1 or PARP monotherapies in difficult-to-treat types of ovarian cancer, regardless of biomarker...

TSRO : 51.58 (-1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor...

See More

Key Turning Points

2nd Resistance Point 53.79
1st Resistance Point 52.68
Last Price 51.58
1st Support Level 50.86
2nd Support Level 50.15

See More

52-Week High 168.92
Fibonacci 61.8% 123.75
Fibonacci 50% 109.79
Fibonacci 38.2% 95.84
Last Price 51.58
52-Week Low 50.67

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar